<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16101">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02897271</url>
  </required_header>
  <id_info>
    <org_study_id>2016-4349</org_study_id>
    <secondary_id>5U54AI117804-03</secondary_id>
    <nct_id>NCT02897271</nct_id>
  </id_info>
  <brief_title>Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort</brief_title>
  <official_title>Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Office of Rare Diseases (ORD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Advancing Translational Science (NCATS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate features of patients with Eosinophilic
      Gastrointestinal Disorders (EGIDs) other than Eosinophilic Esophagitis (EoE) alone,
      including Eosinophilic Gastritis (EG), Eosinophilic Gastroenteritis (EGE), and Eosinophilic
      Colitis (EC).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This retrospective chart review study will analyze the demographics, medical history,
      clinical features, and pathological data of patients with Eosinophilic Gastrointestinal
      Disorders (EGIDs) other than Eosinophilic Esophagitis (EoE) alone, including Eosinophilic
      Gastritis (EG), Eosinophilic Gastroenteritis (EGE), and Eosinophilic Colitis (EC).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mucosal eosinophilia (eos/hpf)</measure>
    <time_frame>Duration of funding, approximately 5 years</time_frame>
    <description>Mucosal eosinophil levels are measured as eosinophils per high power field (eos/hpf). The primary outcome measure is to determine the change in mucosal eosinophil level (eos/hpf) and to determine if the change in mucosal eosinophil level in eos/hpf correlates with other measures of disease activity.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Eosinophilic Esophagitis</condition>
  <condition>Eosinophilic Gastritis</condition>
  <condition>Eosinophilic Gastroenteritis</condition>
  <condition>Eosinophilic Colitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Male or female patients of any age with a diagnosis of eosinophilic gastrointestinal
        disorder (EGID) other than eosinophilic esophagitis (EoE) alone, including eosinophilic
        gastritis (EG), eosinophilic gastroenteritis (EGE), and eosinophilic colitis (EC).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of an EGID including EG, EGE, and/or EC. Subjects with EoE can be included
             if they also have another EGID.

          -  Clinical symptoms of gastrointestinal dysfunction.

          -  Findings of increased eosinophils on tissue biopsy at the time of diagnosis, before
             treatment initiated.

          -  Exclusion of other causes of gastrointestinal eosinophilia.

        Exclusion Criteria:

          -  Gastrointestinal eosinophilia caused by another disorder.

          -  Diagnosis of EoE without another EGID.

          -  Insufficient medical record or pathology data available to support an EGID diagnosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc E Rothenberg, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jonathan Kuhl, BS</last_name>
    <phone>513-803-3078</phone>
    <email>jonathan.kuhl@cchmc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Melody Hess, MS</last_name>
    <phone>513-636-5540</phone>
    <email>melody.hess@cchmc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Arkansas for Medical Science</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Pesek, MD</last_name>
      <phone>501-364-1060</phone>
      <email>rdpesek@uams.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Pesek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lea Jacinto</last_name>
      <phone>858-246-2144</phone>
      <email>ljacinto@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Seema Aceves, M.D., PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susanna Kantor</last_name>
      <phone>720-777-4200</phone>
      <email>susanna.kantor@childrenscolorado.org</email>
    </contact>
    <investigator>
      <last_name>Glenn Furuta, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angelika Zalewski</last_name>
      <phone>312-695-4054</phone>
      <email>angelika.zalewski@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Ikuo Hirano, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ann and Robert H. Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jessica Ross</last_name>
      <email>JNRoss@luriechildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Kristin Johnson</last_name>
      <email>KrJohnson@luriechildrens.org</email>
    </contact_backup>
    <investigator>
      <last_name>Barry Wershil, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Riley Children's Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cindy Sawyers</last_name>
      <email>clsawyer@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Sandeep Gupta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts University School of Medicine</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pedro Eman</last_name>
      <phone>617-636-4941</phone>
      <email>peman@tuftsmedicalcenter.org</email>
    </contact>
    <investigator>
      <last_name>John Leung, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina, Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sarah McGee</last_name>
      <phone>919-966-4591</phone>
      <email>smcgee@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Evan Dellon, M.D., MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Kuhl, BS</last_name>
      <phone>513-803-3078</phone>
      <email>jonathan.kuhl@cchmc.org</email>
    </contact>
    <investigator>
      <last_name>J. Pablo Abonia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maureen Demarshall</last_name>
      <phone>215-349-8546</phone>
      <email>demarshm@mail.med.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Gary Falk, M.D., MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.rarediseasesnetwork.org/cms/CEGIR</url>
    <description>Rare Diseases Clinical Research Network website</description>
  </link>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 20, 2017</lastchanged_date>
  <firstreceived_date>September 2, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Eosinophilic Gastrointestinal Disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Esophagitis</mesh_term>
    <mesh_term>Gastroenteritis</mesh_term>
    <mesh_term>Eosinophilic Esophagitis</mesh_term>
    <mesh_term>Gastritis</mesh_term>
    <mesh_term>Enteritis</mesh_term>
    <mesh_term>Eosinophilia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
